This test is most useful if any of these apply to you.
Intestinal parasites are among the most underdiagnosed causes of chronic digestive symptoms worldwide. Traditional stool testing relies on a technician physically spotting parasites or their eggs under a microscope, a method that misses infections roughly 40% to 60% of the time on a single sample. DNA-based testing (called PCR, for polymerase chain reaction) changes that equation by detecting the genetic material of parasites directly, even when organisms are too few or too degraded for a human eye to catch.
This panel targets six parasites that together account for the vast majority of gut infections caused by single-celled organisms (called protozoa) seen in clinical practice. Running all six in a single stool sample means you get a yes or no answer for each organism at once, without the delays, repeat collections, or guesswork that come with older methods.
The six organisms on this panel fall into two broad clinical categories: parasites that nearly always cause disease when present, and parasites whose significance depends on context. Understanding this distinction matters, because a positive result does not always mean the same thing.
Giardia is the most common disease-causing intestinal parasite in developed countries. It attaches to the lining of the small intestine and disrupts fat absorption, causing greasy diarrhea, bloating, and weight loss. A large meta-analysis of diagnostic studies found that PCR detects Giardia with a sensitivity of approximately 96% to 100%, compared with roughly 50% to 70% for a single microscopy exam. Post-infectious irritable bowel syndrome (IBS), where digestive symptoms continue after the infection is cleared, develops in a substantial proportion of people after Giardia infection, making early detection and treatment directly relevant to long-term gut health.
Cryptosporidium causes watery diarrhea that can last weeks in healthy adults and become dangerous in anyone with a weakened immune system. Traditional microscopy requires a specialized stain that many labs do not run unless specifically requested. PCR eliminates that gap. Entamoeba histolytica is the parasite responsible for amoebic dysentery (severe bloody diarrhea caused by tissue invasion) and, in rare cases, liver abscesses. Microscopy cannot reliably distinguish it from the harmless look-alike Entamoeba dispar, but PCR can, preventing both missed diagnoses and unnecessary treatment.
Cyclospora cayetanensis causes prolonged, relapsing diarrhea and is linked to contaminated fresh produce. It is notoriously difficult to spot on microscopy because its egg-like cysts (called oocysts) are tiny and shed intermittently. PCR-based detection has shown substantially higher sensitivity than traditional microscopy for this organism.
Blastocystis is found in the stool of roughly 5% to 15% of people in high-income countries and far more in tropical regions. Whether it causes symptoms is still debated. Some subtypes, particularly subtypes 1 through 4, have been associated with IBS-like symptoms in case-control studies, while other carriers remain entirely asymptomatic. A positive Blastocystis result on this panel should be interpreted alongside your symptoms, not as an automatic reason to treat.
Dientamoeba fragilis occupies a similar gray zone. Prevalence studies in developed countries report detection rates of 2% to 20% depending on the population and method used. It has been associated with abdominal pain and loose stools in some clinical series, but treatment trials have shown inconsistent results. If you are symptomatic and this organism is the only finding, a conversation with a clinician about a treatment trial may be warranted.
Standard stool microscopy (often called ova and parasite exam, or O&P) has been the default for decades, but it has well-documented weaknesses. A single O&P exam misses roughly half of infections. Guidelines have traditionally recommended collecting three separate stool specimens on different days to improve sensitivity, which creates logistical friction that often means the second and third samples never get submitted.
PCR solves several of these problems at once. A single stool sample is sufficient. Sensitivity for the major pathogens typically exceeds 95%. And for Entamoeba histolytica, PCR is the only reliable way to confirm the species, because microscopy cannot distinguish it from at least two nonpathogenic species that look identical.
PCR results for each organism are reported as detected or not detected. There is no numeric scale or range. The value of running all six together is the pattern that emerges.
| Pattern | What It Suggests | Next Step |
|---|---|---|
| Giardia detected, all others negative | Classic Giardia infection. The most common single-parasite finding. | Treat with antiparasitic medication. Retest 2 to 4 weeks after treatment to confirm clearance. |
| Entamoeba histolytica detected | True amoebic infection confirmed by DNA. Treatment is needed even without symptoms, because of the risk of invasive disease. | Treat immediately. Consider liver imaging if symptoms include right upper abdominal pain or fever. |
| Blastocystis or Dientamoeba detected alone, with chronic digestive symptoms | Possible but uncertain cause of symptoms. These organisms may or may not be driving your complaints. | Discuss a treatment trial with your clinician. If symptoms resolve, the organism was likely contributing. |
| Multiple parasites detected | Suggests a significant exposure event (contaminated water, travel) or immune vulnerability. | Treat confirmed pathogens first. Investigate exposure source. Consider immune evaluation if recurrent. |
PCR is extremely sensitive, which is usually an advantage but occasionally creates ambiguity. It can detect residual parasite DNA for a short period after successful treatment, producing a positive result when the infection is actually gone. If you are retesting after treatment, wait at least two to three weeks to reduce the chance of a false positive from lingering DNA fragments.
Antibiotics, bismuth-containing medications (like Pepto-Bismol), and certain herbal supplements can interfere with stool PCR by degrading DNA or inhibiting the chemical reaction used to copy and detect it. Stop these at least 48 to 72 hours before collection if possible. Recent colonoscopy prep can also dilute stool and wash out organisms, so wait at least two weeks after a bowel prep before collecting your sample.
A single negative panel is reassuring but not a lifetime guarantee, especially if you travel frequently, drink untreated water, or have ongoing unexplained digestive symptoms. For travelers returning from endemic areas, running this panel within two to four weeks of return captures most infections during their incubation window.
If you tested positive and completed treatment, a follow-up panel confirms eradication. For Giardia in particular, treatment failure rates with standard metronidazole therapy range from 10% to 20% in some studies, making post-treatment confirmation especially valuable. Persistent symptoms after a negative follow-up test may point toward post-infectious IBS or another diagnosis entirely.
If Giardia, Cryptosporidium, Entamoeba histolytica, or Cyclospora is detected, bring your results to a primary care physician or infectious disease specialist. These organisms have well-established treatment protocols. Giardia and Cyclospora respond to specific antibiotics. Entamoeba histolytica requires a two-drug regimen to clear both the active infection and dormant cysts in the gut. Cryptosporidium in healthy adults usually resolves on its own, but antiparasitic treatment can shorten the illness.
If Blastocystis or Dientamoeba fragilis is your only positive result and you have no symptoms, watchful monitoring is reasonable. If you do have symptoms, a gastroenterologist or infectious disease specialist can help you weigh the evidence for treatment. Adding a stool calprotectin test (a marker of intestinal inflammation) can help distinguish whether the gut lining is inflamed alongside the parasite finding.
Parasitology PCR Module is best interpreted alongside these tests.